Translation and Validation of the Chinese Version of the Current Opioid Misuse Measure (COMM) for Patients with Chronic Pain in Mainland China

Overview

Journal Health Qual Life Outcomes

Publisher Biomed Central

Specialty Public Health

Date 2015 Sep 17

PMID 26374505

Citations 4

Authors

Yang Zhao

Yuli Li

Xuekun Zhang

Fenglan Lou

Affiliations

Soon will be listed here.

Abstract

Background: Management of prescription opioids misuse and abuse problems among chronic pain patients has been increasingly important worldwide and little literature concerning prescription opioids can be found in mainland China so far.

Methods: The Current Opioid Misuse Measure (COMM) was translated into Chinese following Brislin's model of cross-culture translation and was completed by a convenience sample of 180 patients with chronic pain recruited from two major hospitals in Jinan, Shandong province. Data were analyzed using internal consistency, test-retest reliability, exploratory factor analysis and confirmatory factor analysis.

Results: The internal consistency coefficient for the total score of the COMM was 0.85 and item-total correlations of all items were above 0.20. Besides, the test-retest reliability was satisfactory with an ICC of 0.91 (95% CI = 0.65-0.98). Four principal components were extracted, accounting for 65.30% of the variance, and the factor loadings of all 17 items were above 0.40.

Conclusions: The Chinese version of COMM showed satisfactory reliability and validity, and could be used as a screening tool to evaluate and monitor current aberrant drug-related behavior among Chinese patients with chronic pain.

Citing Articles

Spanish translation and cultural linguistic validation of the Current Opioid Misuse Measurement (COMM-S).

Mendez-Pino L, Villela-Franyutti D, Schnipper J, Urman R, Corey S, Collins P Pain Med. 2023; 24(9):1119-1121.

PMID: 36882167 PMC: 10695418. DOI: 10.1093/pm/pnad030.

Spanish Validation of the COMM Scale to Assess the Misuse of Prescription Opioids in Patients with Chronic Noncancer Pain.

Reyes-Perez A, Lopez-Martinez A, Esteve R, Ramirez-Maestre C Int J Ment Health Addict. 2022; :1-15.

PMID: 35342377 PMC: 8936043. DOI: 10.1007/s11469-022-00803-3.

A Scoping Review of Nursing's Contribution to the Management of Patients with Pain and Opioid Misuse.

Van Cleave J, Booker S, Powell-Roach K, Liang E, Kawi J Pain Manag Nurs. 2021; 22(1):58-68.

PMID: 33414010 PMC: 7887047. DOI: 10.1016/j.pmn.2020.11.007.

Risk of opioid misuse in chronic non-cancer pain in primary care patients - a cross sectional study.

Just J, Bingener L, Bleckwenn M, Schnakenberg R, Weckbecker K BMC Fam Pract. 2018; 19(1):92.

PMID: 29925323 PMC: 6011396. DOI: 10.1186/s12875-018-0775-9.

References

Meltzer E, Rybin D, Saitz R, Samet J, Schwartz S, Butler S . Identifying prescription opioid use disorder in primary care: diagnostic characteristics of the Current Opioid Misuse Measure (COMM). Pain. 2010; 152(2):397-402. PMC: 3027065. DOI: 10.1016/j.pain.2010.11.006. View

Chou R, Fanciullo G, Fine P, Adler J, Ballantyne J, Davies P . Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009; 10(2):113-30. PMC: 4043401. DOI: 10.1016/j.jpain.2008.10.008. View

Roxburgh A, Bruno R, Larance B, Burns L . Prescription of opioid analgesics and related harms in Australia. Med J Aust. 2011; 195(5):280-4. DOI: 10.5694/mja10.11450. View

Hartrick C, Gatchel R, Conroy S . Identification and management of pain medication abuse and misuse: current state and future directions. Expert Rev Neurother. 2012; 12(5):601-10. DOI: 10.1586/ern.12.34. View

Fischer B, Argento E . Prescription opioid related misuse, harms, diversion and interventions in Canada: a review. Pain Physician. 2012; 15(3 Suppl):ES191-203. View

Manchikanti L, Helm 2nd S, Fellows B, Janata J, Pampati V, Grider J . Opioid epidemic in the United States. Pain Physician. 2012; 15(3 Suppl):ES9-38. View

Smith S, Dart R, Katz N, Paillard F, Adams E, Comer S . Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain. 2013; 154(11):2287-2296. PMC: 5460151. DOI: 10.1016/j.pain.2013.05.053. View

Finkelman M, Kulich R, Zoukhri D, Smits N, Butler S . Shortening the Current Opioid Misuse Measure via computer-based testing: a retrospective proof-of-concept study. BMC Med Res Methodol. 2013; 13:126. PMC: 4016584. DOI: 10.1186/1471-2288-13-126. View

Adams L, Gatchel R, Robinson R, Polatin P, Gajraj N, Deschner M . Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J Pain Symptom Manage. 2004; 27(5):440-59. DOI: 10.1016/j.jpainsymman.2003.10.009. View

10.

Passik S, Kirsh K, Whitcomb L, Portenoy R, Katz N, Kleinman L . A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther. 2004; 26(4):552-61. DOI: 10.1016/s0149-2918(04)90057-4. View

11.

Butler S, Budman S, Fernandez K, Jamison R . Validation of a screener and opioid assessment measure for patients with chronic pain. Pain. 2004; 112(1-2):65-75. DOI: 10.1016/j.pain.2004.07.026. View

12.

Butler S, Budman S, Fernandez K, Houle B, Benoit C, Katz N . Development and validation of the Current Opioid Misuse Measure. Pain. 2007; 130(1-2):144-56. PMC: 1950245. DOI: 10.1016/j.pain.2007.01.014. View

13.

Polit D, Tatano Beck C . The content validity index: are you sure you know what's being reported? Critique and recommendations. Res Nurs Health. 2006; 29(5):489-97. DOI: 10.1002/nur.20147. View

14.

Dhalla I, Mamdani M, Sivilotti M, Kopp A, Qureshi O, Juurlink D . Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ. 2009; 181(12):891-6. PMC: 2789126. DOI: 10.1503/cmaj.090784. View

15.

Butler S, Budman S, Fanciullo G, Jamison R . Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy. Clin J Pain. 2010; 26(9):770-6. PMC: 2955853. DOI: 10.1097/AJP.0b013e3181f195ba. View

16.

Bartko J . The intraclass correlation coefficient as a measure of reliability. Psychol Rep. 1966; 19(1):3-11. DOI: 10.2466/pr0.1966.19.1.3. View

17.

Compton P, Darakjian J, Miotto K . Screening for addiction in patients with chronic pain and "problematic" substance use: evaluation of a pilot assessment tool. J Pain Symptom Manage. 1999; 16(6):355-63. DOI: 10.1016/s0885-3924(98)00110-9. View

18.

Wakefield D, Wakefield B, Borders T, Blegen M, Vaughn T . Understanding why medication administration errors may not be reported. Am J Med Qual. 1999; 14(2):81-8. DOI: 10.1177/106286069901400203. View

19.

Webster L, Webster R . Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005; 6(6):432-42. DOI: 10.1111/j.1526-4637.2005.00072.x. View

20.

Sousa V, Rojjanasrirat W . Translation, adaptation and validation of instruments or scales for use in cross-cultural health care research: a clear and user-friendly guideline. J Eval Clin Pract. 2010; 17(2):268-74. DOI: 10.1111/j.1365-2753.2010.01434.x. View